ReviewCell death and differentiation2023
The BCL2 inhibitor venetoclax mediates anticancer effects through dendritic cell activation.
Peng Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this paperpooled itcites it